Should All Patients with Indolent Lymphoma Be Treated with Rituximab Maintenance Therapy? An Overview of the Data Fulltext Access 4 Pages 2006
Strontium ranelate: An increased bone quality leading to vertebral antifracture efficacy at all stages Fulltext Access 4 Pages 2006
Strontium ranelate: A physiological approach for an improved bone quality Fulltext Access 4 Pages 2006
Eastern Cooperative Oncology Group 4402: Rituximab Extended Schedule or Retreatment Trial (RESORT) Fulltext Access 4 Pages 2006
Classical Hodgkin's Lymphoma Presenting with Tongue Involvement: A Case Report and Review of the Literature Fulltext Access 4 Pages 2006
Antiviral and Immunomodulatory Treatment for AIDS-Related Primary Central Nervous System Lymphoma: AIDS Malignancies Consortium Pilot Study 019 Fulltext Access 4 Pages 2006
Treatment for Relapse in Stage I/II Hodgkin's Lymphoma After Initial Single-Modality Treatment Fulltext Access 4 Pages 2006
Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia Fulltext Access 4 Pages 2006
Activity of Rituximab Monotherapy in Refractory Splenic Marginal Zone Lymphoma Complicated with Autoimmune Hemolytic Anemia Fulltext Access 4 Pages 2006
“Low BMD is less predictive than reported falls for future limb fractures in women across Europe: Results from the European Prospective Osteoporosis Study (EPOS).” Reply to letter to the editor by Pijpers et al. Fulltext Access 4 Pages 2006
Angiogenetic Factors and Biochemical Markers of Bone Metabolism in POEMS Syndrome Treated with High-Dose Therapy and Autologous Stem Cell Support Fulltext Access 4 Pages 2006
Weekly Bortezomib/Methylprednisolone is Effective and Well Tolerated in Relapsed Multiple Myeloma Fulltext Access 4 Pages 2006
Lack of HLA-E surface expression is due to deficiency of HLA-E transcripts in the malignant hematopoietic cells of leukemic patients Fulltext Access 4 Pages 2006
WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder Fulltext Access 4 Pages 2006
Hypertrophic osteoarthropathy and intrathoracic Hodgkin's disease in children Fulltext Access 4 Pages 2006
Digitoxin, at concentrations commonly found in the plasma of cardiac patients, antagonizes etoposide and idarubicin activity in K562 leukemia cells Fulltext Access 4 Pages 2006
Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis Fulltext Access 4 Pages 2006
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older Fulltext Access 4 Pages 2006
The complex between activated protein C and protein C inhibitor: A clinically useful indicator of aortic aneurysms? Fulltext Access 4 Pages 2006
The functions of plasminogen activator inhibitor-1: Do we have all the pieces of PAI? Fulltext Access 4 Pages 2006
Genotyping the HFE gene by melting point analysis with the LightCycler system: Pros and cons Fulltext Access 4 Pages 2006
Membrane protein carbonylation in non-leukodepleted CPDA-preserved red blood cells Fulltext Access 4 Pages 2006
Novel and Mediterranean β thalassemia mutations in the indigenous Northern Ireland population Fulltext Access 4 Pages 2006
Prevalence of −α3.7 and αααanti3.7 alleles in sickle cell trait and β-thalassemia patients in Mexico Fulltext Access 4 Pages 2006
The intrinsic pathway of coagulation is essential for thrombus stability in mice Fulltext Access 4 Pages 2006
Tissue factor pathway vs. collagen pathway for in vivo platelet activation Fulltext Access 4 Pages 2006
Searching for hemostatic modifier genes affecting the phenotype of mice with very low levels of FVII Fulltext Access 4 Pages 2006
Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes Fulltext Access 4 Pages 2006
Mutation analysis of Gaucher disease patients in Taiwan: High prevalence of the RecNciI and L444P mutations Fulltext Access 4 Pages 2006
Angelica stimulates proliferation of murine bone marrow mononuclear cells by the MAPK pathway Fulltext Access 4 Pages 2006
Hematologically important mutations: Bilirubin UDP-glucuronosyltransferase gene mutations in Gilbert and Crigler–Najjar syndromes Fulltext Access 4 Pages 2006
National health budgets for expensive orphan drugs: Gaucher disease in Israel as a model Fulltext Access 4 Pages 2006
Thalassemia and hemoglobinopathies rather than iron deficiency are major causes of pregnancy-related anemia in northeast Thailand Fulltext Access 4 Pages 2006
Mutational analysis of PDGFR–RAS/MAPK pathway activation in childhood medulloblastoma Fulltext Access 4 Pages 2006
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia Fulltext Access 4 Pages 2006
Past chlamydial infection is not associated with primary fallopian tube carcinoma Fulltext Access 4 Pages 2006
Thyroid metastases from colorectal cancer: The Institut Gustave Roussy experience Fulltext Access 4 Pages 2006
The role of complementary and alternative medicine in the management of early breast cancer: Recommendations of the European Society of Mastology (EUSOMA) Fulltext Access 4 Pages 2006
Is MSI-H of value in predicting the development of metachronous colorectal cancer? Fulltext Access 4 Pages 2006
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level Fulltext Access 4 Pages 2006
Chewing gum and risk of oesophageal adenocarcinoma: A new hypothesis tested in a population-based study Fulltext Access 4 Pages 2006
Depleted uranium and cancer in Danish Balkan veterans deployed 1992–2001 Fulltext Access 4 Pages 2006
A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: The Finnish Ovarian Cancer (FINOVA) study Fulltext Access 4 Pages 2006
C-reactive protein levels and subsequent cancer outcomes: Results from a prospective cohort study Fulltext Access 4 Pages 2006
Intraoperative sentinel lymph node examination by frozen section, immunohistochemistry and imprint cytology during breast surgery - A prospective study Fulltext Access 4 Pages 2006
The multidisciplinary meeting: An indispensable aid to communication between different specialities Fulltext Access 4 Pages 2006
Reconstitution of T Cell Subset Repertoire Diversity following Multiple Antigen-Mismatched Bone Marrow Transplantation Fulltext Access 4 Pages 2006
Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease: Does It Work? Fulltext Access 4 Pages 2006
Using Genomics to Identify High-Risk Myeloma after Autologous Stem Cell Transplantation Fulltext Access 4 Pages 2006
Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia Following Nonmyeloablative Conditioning Using 200-cGy Total Body Irradiation and Fludarabine Fulltext Access 4 Pages 2006
Reduced Intensity Conditioning for Allogeneic Stem Cell Transplantation in Relapsed and Refractory Hodgkin Lymphoma: Where Do We Stand? Fulltext Access 4 Pages 2006
JAK2V617F and leukemic transformation in myelofibrosis with myeloid metaplasia Fulltext Access 4 Pages 2006
Microcytosis in agnogenic myeloid metaplasia: Prevalence and clinical correlates Fulltext Access 4 Pages 2006
Addition of sargramostim (GM-CSF) to imatinib results in major cytogenetic response in a patient with chronic myeloid leukemia Fulltext Access 4 Pages 2006
Lymphoma cells protected from apoptosis by dysregulated bcl-2 continue to bind Annexin V in response to B-cell receptor engagement: A cautionary tale Fulltext Access 4 Pages 2006
Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia Fulltext Access 4 Pages 2006
Variation of LEF-1 mRNA expression in low-grade B-cell non-Hodgkin's lymphoma Fulltext Access 4 Pages 2006
Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma Fulltext Access 4 Pages 2006
Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia Fulltext Access 4 Pages 2006
Development of a mantle cell lymphoma in an ATM heterozygous woman after occupational exposure to ionising radiation and somatic mutation of the second allele Fulltext Access 4 Pages 2006
In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations Fulltext Access 4 Pages 2006
Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia Fulltext Access 4 Pages 2006
Chronic lymphocytic leukaemia: Is terminal del(14)(q24) a new marker for prognostic stratification? Fulltext Access 4 Pages 2006
Low dose antithymocyte globulin for the treatment of older patients with aplastic anaemia Fulltext Access 4 Pages 2006
Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma Fulltext Access 4 Pages 2006
Endothelial cell apoptosis in the context of quantification of angiogenesis in solid human adenocarcinomas: A novel double immunolabelling technique to identify endothelial cell apoptosis Fulltext Access 4 Pages 2006
The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes Fulltext Access 4 Pages 2006